Press release
Low Molecular Weight Heparin Market worth USD 8.5 billion by 2032 - Changzhou Qianhong Bio-pharma, LEOPHARMA A/S, Teva Pharmaceutical Industries Ltd.
Low Molecular Weight Heparin market
To Remain 'Ahead' Of Your Competitors, Request for A Sample - https://www.globalinsightservices.com/request-sample/GIS10497
Low molecular weight heparin (LMWH) is a class of anticoagulants. They are used to treat venous thromboembolism (deep vein thrombosis and pulmonary embolism) and myocardial infarction, and prevent blood clots. Low molecular weight heparin offers more advantages than heparin as it has better bioavailability, longer half-life, simplified dosing, predictable anticoagulant response, lower HIT risk, and lower osteoporosis risk.
LMWH can be administered subcutaneously once or twice daily without coagulation monitoring, even when the drug is administered in treatment doses. Most patients do not require coagulation monitoring with LMWH. The effects of unfractionated heparin (UFH) or standard heparin vary from patient to patient. Therefore, it can only be administered to hospitalized patients under supervision. In addition, the LMWH has more predictable pharmacokinetic properties than unfractionated heparin, which allows its administration in fixed doses based on laboratory monitoring, without the need for dose adjustments.
Read more about Low Molecular Weight Heparin market here: https://www.globalinsightservices.com/reports/low-molecular-weight-heparin-market/
Market Trends and Drivers
Developments by Companies to Drive Low Molecular Weight Heparin Market:
The Shenzhen Panorama Network has increased the production of new LMWH products to expand its presence in the market. In May 2020, Meitheal Pharmaceuticals Inc. received an FDA approval for Enoxaparin Sodium Injection (USP), a generic equivalent of Lovenox. The increasing propensity of research institutes to encourage the use of LMWH in new treatments would boost its demand in the future. The LMWH helps improve coagulation disorder occurring in COVID-19 patients; it exerts anti-inflammatory effects by reducing IL-6 and stimulating lymphocyte percentage. This application of LMWH is paving the way for well-controlled clinical trials in the field of COVID-19.
The American University of Beirut Medical Center is sponsoring a study of bemiparin sodium (a form of LMWH), which is in Phase IV clinical trials that are being conducted for its ability to improve pregnancy outcomes in patients with recurrent implantation failure, who are undergoing IVF/ICSI treatment. In addition, important players in the market are working with hospitals to strengthen their product portfolio. For example, Bayer is working with Assistance Publique - Hopitaux de Paris to investigate the combination of rivaroxaban and low molecular weight heparin against neoplasms and venous thromboembolism, which is in the Phase 3 trial.
Major Players in the Global Low Molecular Weight Heparin Market
Market players are focusing on strategic collaborations to enhance their product offerings. Some prominent participants in the global Low Molecular Weight Heparin market include Aspen Holdings, Changzhou Qianhong Bio-pharma, LEOPHARMA A/S, Teva Pharmaceutical Industries Ltd., B. Braun Medical Inc., Pfizer Inc., Sanofi-Aventis, Dr. Reddy's Laboratories Limited, and Abbott among others.
COVID-19 Impact
The spread of the COVID-19 pandemic has emphasized health data sharing and interoperability under the microscope. The infection of novel coronavirus in children is mild compared to adults, and children are assigned a better prognosis. The interruptions in the supply chain and the massive demand for efficient treatments for COVID-19 have put the health research industry in Asia-Pacific in a crucial position.
Get Customized Report as Per Your Requirement - https://www.globalinsightservices.com/request-customization/GIS10497
Global Low Molecular Weight Heparin Market Segmentation
By Drug Type
Enoxaparin
Dalteparin
Nadroparin
Bemiparin
Tinzaparin
Others
Buy Now - https://www.globalinsightservices.com/checkout/single_user/GIS10497
By Packaging
Multi-vials
Prefilled Syringes
By Application
Deep Vein Thrombosis
Acute Coronary Syndrome (ACS)
Pulmonary Embolism
Atrial Fibrillation
By End-user
Hospitals
Clinics
Ambulatory Surgical Centers
With Global Insight Services, you receive:
10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
New Report Published by Global Insight Services: https://www.globalinsightservices.com/reports/hydrogen-projects-database/
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Low Molecular Weight Heparin Market worth USD 8.5 billion by 2032 - Changzhou Qianhong Bio-pharma, LEOPHARMA A/S, Teva Pharmaceutical Industries Ltd. here
News-ID: 3084550 • Views: …
More Releases from Global Insight Services
Hydrogen Generation Market Poised to Grow from $155.5 Billion in 2024 to $410.6 …
The Hydrogen Generation Market is set to experience remarkable growth, expanding from $155.5 billion in 2024 to an estimated $410.6 billion by 2034, registering a robust CAGR of approximately 10.2%. Hydrogen generation involves producing and supplying hydrogen through various techniques, including steam methane reforming, electrolysis, and coal gasification. This market plays a pivotal role in supporting industries seeking cleaner energy solutions, spanning transportation, power generation, and industrial processes. As the…
Identity and Access Management Market Poised to Grow from $15.9 Billion in 2024 …
The Identity & Access Management (IAM) market is poised for substantial growth, expanding from an estimated $15.9 billion in 2024 to $38.2 billion by 2034 at a robust CAGR of approximately 9.2%. IAM encompasses systems, tools, and policies that manage digital identities and regulate user access within organizations. This includes solutions such as authentication, single sign-on, identity governance, and privileged access management. These technologies are essential for ensuring security, compliance,…
Endoscopy Devices Market Is Anticipated To Expand From $14.5 Billion In 2024 To …
Market Overview
The Endoscopy Devices Market is playing an increasingly important role in modern healthcare by supporting minimally invasive diagnostic and surgical procedures. These devices, which include endoscopes, visualization systems, and complementary instruments, allow physicians to examine internal organs with precision, leading to faster diagnoses, less trauma for patients, and improved recovery times. As the global burden of chronic diseases rises, the demand for such technologies continues to expand. Additionally, advancements…
Sustainable Fashion Market Is Anticipated To Expand From $13.8 Billion In 2024 T …
Market Overview
The Sustainable Fashion Market has gained remarkable momentum in recent years as consumers, brands, and policymakers increasingly recognize the need for eco-friendly and socially responsible alternatives in the fashion industry. Unlike conventional fashion, which is often criticized for its high carbon footprint and exploitative labor practices, sustainable fashion emphasizes the use of organic, recycled, and biodegradable materials, along with ethical supply chains and fair trade principles. This shift represents…
More Releases for Molecular
Molecular Breeding Market Report 2024 - Molecular Breeding Market Size, Share An …
"The Business Research Company recently released a comprehensive report on the Global Molecular Breeding Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The molecular breeding market size…
Molecular Quality Controls: Ensuring Precision and Reliability in Molecular Diag …
Introduction
Molecular quality controls (MQCs) play a critical role in molecular diagnostics, helping laboratories and healthcare providers ensure the accuracy, reliability, and consistency of diagnostic tests. These quality controls are essential in detecting and monitoring infectious diseases, genetic disorders, cancer biomarkers, and other molecular targets. By providing standards that verify the performance of diagnostic assays, MQCs help reduce errors, minimize false results, and maintain compliance with regulatory standards. As the demand…
Molecular Diagnostic Platform Market Advancing Molecular Diagnostics with Innova …
Global Molecular Diagnostic Platform Market Overview:
The Molecular Diagnostic Platform market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the Molecular Diagnostic Platform market has experienced significant growth, driven by factors such as increasing consumer demand, technological advancements, and globalization. This growth…
Molecular Modeling Market - Visualizing the unseen: Molecular modeling for grou …
Newark, New Castle, USA: The "Molecular Modeling Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Molecular Modeling Market: https://www.growthplusreports.com/report/molecular-modeling-market/8615
This latest report researches the industry structure, sales, revenue,…
Molecular Diagnostics Market - Empowering healthcare through molecular precision …
Newark, New Castle, USA: The "Molecular Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Molecular Diagnostics Market: https://www.growthplusreports.com/report/molecular-diagnostics-market/7674
This latest report researches the industry structure, sales, revenue,…
Molecular Imaging Device Market scenario for 2022 | Trivitron Healthcare, Molecu …
The Molecular Imaging Device market report anticipate the market growth and recent developments in market competition which helps players to strategies and analysis the position in Molecular Imaging Device market. It also indicates the risk factors, advancements, market drivers, revenue, business scenario, growth potential, market scope, new trends, and historical data of Molecular Imaging Device market. With this futuristic approach researchers also provides a close study of market forecast, overview…
